|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/08 | |
| A61K 9/19 | |||
| A61K 47/12 | |||
| A61K 9/00 | |||
| A61K 31/401 |
| (11) | Number of the document | 2618814 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11761049.3 |
| Date of filing the European patent application | 2011-09-19 | |
| (97) | Date of publication of the European application | 2013-07-31 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/066202 |
| Date | 2011-09-19 |
| (87) | Number | WO 2012/038371 |
| Date | 2012-03-29 |
| (30) | Number | Date | Country code |
| 384333 P | 2010-09-20 | US |
| (72) |
SHIRODE, Swapnil P., IN
PATEL, Piysh, IN
PATIL, Atul, IN
GIDWANI, Suresh, IN
PARIKH, Neil, US
MOCNIK, Anita Bevetek, HR
|
| (73) |
Xellia Pharmaceuticals ApS,
Dalslandsgade 11, 2300 Copenhagen S,
DK
|
| (54) | CASPOFUNGIN COMPOSITION |
| CASPOFUNGIN COMPOSITION |